Actuate Therapeutics (ACTU) Gains from Investment Securities (2023 - 2024)
Actuate Therapeutics (ACTU) posted quarterly Gains from Investment Securities of -$193951.0 for Q3 2024, down 1049.95% year-over-year from $20416.9 in Q4 2023, and down 180.7% quarter-over-quarter from $240339.0 in Q2 2024.
Actuate Therapeutics (ACTU) Gains from Investment Securities (2023 - 2024) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Gains from Investment Securities for 2 consecutive years, with -$193951.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Gains from Investment Securities fell 1049.95% year-over-year to -$193951.0; the TTM figure through Jun 2025 stood at -$193951.0 (down 163.06% YoY), while the FY2024 annual figure was $78903.0, down 1.15% from the prior year.
- Gains from Investment Securities eased to -$193951.0 in Q3 2024 per ACTU's latest filing, from $240339.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $240339.0 in Q2 2024 and bottomed at -$193951.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -193,951.00 |
| Sep 30, 2024 | -193,951.00 |
| Jun 30, 2024 | 240,339.00 |
| Jun 30, 2024 | 240,339.00 |
| Mar 31, 2024 | 32,515.00 |
| Mar 31, 2024 | 32,515.00 |
| Dec 31, 2023 | 51,598.00 |
| Dec 31, 2023 | 51,598.00 |
| Sep 30, 2023 | -16,866.00 |
| Sep 30, 2023 | -16,866.00 |
| Jun 30, 2023 | 50,194.00 |
| Jun 30, 2023 | 50,194.00 |